Deficiencies in the covalent binding idnex (CBI) for expressing in vivo binding to DNA with respect to predicting chemical carcinogenicity: A proposal for a target-organ binding index
- 31 March 1987
- journal article
- Published by Elsevier in Mutation Research Letters
- Vol. 190 (3) , 173-175
- https://doi.org/10.1016/0165-7992(87)90024-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The disposition and in vivo covalent binding to liver DNA of the monoazodyes 6-(p-dimethylaminophenylazo)benzothiazole (6BT) and 5-(p-dimethylaminophenylazo) indazole (51) after administration to the ratCarcinogenesis: Integrative Cancer Research, 1986
- Postlabeling methods for carcinogen-DNA adduct analysis.Environmental Health Perspectives, 1985
- Chemical and biochemical dosimetry of exposure to genotoxic chemicals.Environmental Health Perspectives, 1985
- Relationships between DNA adduct formation and carcinogenesis.Environmental Health Perspectives, 1985
- 6-p-Dimethylaminophenylazobenzothiazole: A potent hepatocarcinogen in the ratCancer Letters, 1983
- 32P-postlabeling analysis of non-radioactive aromatic carcinogen — DNA adductsCarcinogenesis: Integrative Cancer Research, 1982
- Searches for ultimate chemical carcinogens and their reactions with cellular macromoleculesCancer, 1981
- In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesisMutation Research/Reviews in Genetic Toxicology, 1979
- Carcinogenic activity of analogs of p-dimethylaminoazobenzene. IX. Activity of the quinoxaline and indazole analogsJournal of Medicinal Chemistry, 1969
- Carcinogenic activity of analogs of p-dimethylaminoazobenzene. VI. Activity of the benzimidazole and benzthiazole analogsJournal of Medicinal Chemistry, 1968